±¸ÀÔó ¹®ÀÇ Á¦Ç°°Ë»ö  FAQ  QNA  ÀÎÀçä¿ë  ¸¶À̳ì½Ç  ¹Ì¿¡·Î  ·çÇÎ  ¶ó´Ï¾Æ  À¯¸°Å¸¹Î  ·¦Å¬  ¸¶À̳켿  ¾ÆÆ®¿¥Äܼ­Æ®  °øÁ¤°Å·¡À§¿øÈ¸  Çѱ¹¼ÒºñÀÚ¿ø
¿µ»ó±¤°í
ÀμⱤ°í
´º½º¾Ø ¹Ìµð¾î
Home >¿Â¶óÀÎÈ«º¸½Ç>´º½º&¹Ìµð¾î  
 
 
´º½º&¹Ìµð¾î
.    1053 1/71
Á¦¸ñ
Çö´ë¾àǰ, ADA¿¡¼­ ´ç´¢º´ Ä¡·áÁ¦ ½Å¾à Èĺ¸¹°Áú ÀÓ»ó 1»ó °á°ú ¹ßÇ¥
¸Åü
Çö´ë¾àǰ
¸µÅ©
³»¿ë
Çö´ë¾àǰÀº 12ÀϺÎÅÍ ÁøÇàµÈ ¹Ì±¹´ç´¢º´ÇÐȸ ¿¬·ÊÇà»ç(2020 ADA, American Diabetes Association)¿¡¼­ °æ±¸¿ë Á¦2Çü ´ç´¢º´ Ä¡·áÁ¦·Î °³¹ß ÁßÀÎ 'HD-6277(HDNO-1605)'ÀÇ ÀÓ»ó 1»ó °á°ú¸¦ ¹ßÇ¥Çß´Ù.

¡®HD-6277(HDNO-1605)¡¯Àº Ç÷´ç ÀÇÁ¸ÀûÀ¸·Î ü³» Àν¶¸° ºÐºñ´ÉÀ» °³¼±ÇÑ´Ù°í ¾Ë·ÁÁø GPR40 agonist ±âÀüÀÇ ¾à¹°·Î, Çö´ë¾àǰÀÌ Áö³­ 2013³â ¹üºÎó, 2015³â º¸°Çº¹ÁöºÎ·ÎºÎÅÍ Áö¿øÀ» ¹Þ¾Æ ÀÚü±â¼ú·ÂÀ¸·Î °³¹ßÀ» ÃßÁøÇϰí ÀÖ´Â ½Å¾àÀÌ´Ù.

Çö´ë¾àǰÀº 2019³â ¹Ì±¹´ç´¢º´ÇÐȸ¿¡¼­ ÀÓ»ó 1»ó °á°ú Áß °Ç°­ÇÑ Áö¿øÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ ´Üȸ ¶Ç´Â ¹Ýº¹ Åõ¿© °á°ú¸¦ °ø°³Çѵ¥ À̾î COVID-19·Î ÀÎÇØ ¿Â¶óÀο¡¼­ ÁøÇàµÇ´Â À̹ø ¹Ì±¹´ç´¢º´ÇÐȸ¿¡¼­ Á¦2Çü ´ç´¢º´ ȯÀÚ¿¡°Ô ¡®HD-6277(HDNO-1605)¡¯ÀÇ ¹Ýº¹ Åõ¿©¿¡ ÀÇÇÑ ¾àµ¿ÇÐÀû °üÂû°á°ú¿Í ÇÔ²² ¾ÈÀü¼º ¹× ³»¾à¼ºÀÌ È®ÀεǾúÀ½À» ¹ßÇ¥Çß´Ù.

Çö´ë¾àǰÀº ¡®HD-6277(HDNO-1605)¡¯ÀÇ Á¦ 2Çü ´ç´¢º´ ȯÀÚ¿¡¼­ÀÇ Ä¡·áÈ¿°ú¸¦ Ž»öÀûÀ¸·Î È®ÀÎÇϱâ À§ÇÑ 2»ó ÀÓ»ó½ÃÇè°èȹÀ» Áö³­ 4¿ù ¹Ì±¹ FDA·Î ºÎÅÍ ½ÂÀÎ¹Þ¾Æ °³¹ß¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ´Ù.

   
 
¹øÈ£
Á¦¸ñ
¸Åü
ÀÛ¼ºÀÏ
Çö´ë¾àǰ
2025-02-12
1081
Çö´ë¾àǰ
2025-07-11
1080
Çö´ë¾àǰ
2025-06-24
1079
Çö´ë¾àǰ
2025-06-19
1078
Çö´ë¾àǰ
2025-06-10
1077
Çö´ë¾àǰ
2025-06-05
1076
Çö´ë¾àǰ
2025-06-04
1075
Çö´ë¾àǰ
2025-05-30
1074
Çö´ë¾àǰ
2025-05-28
1073
Çö´ë¾àǰ
2025-05-19
1072
Çö´ë¾àǰ
2025-05-12
1071
Çö´ë¾àǰ
2025-05-09
1070
Çö´ë¾àǰ
2025-04-25
1069
Çö´ë¾àǰ
2025-04-22
1067
Çö´ë¾àǰ
2025-04-16